Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 5
1953 3
1954 1
1955 2
1956 2
1958 1
1959 1
1964 3
1965 9
1966 13
1967 21
1968 29
1969 19
1970 27
1971 32
1972 46
1973 35
1974 38
1975 25
1976 26
1977 12
1978 24
1979 19
1980 12
1981 14
1982 18
1983 21
1984 13
1985 17
1986 22
1987 21
1988 20
1989 21
1990 20
1991 18
1992 27
1993 22
1994 41
1995 28
1996 36
1997 38
1998 41
1999 45
2000 50
2001 49
2002 67
2003 62
2004 67
2005 66
2006 56
2007 68
2008 77
2009 72
2010 62
2011 58
2012 75
2013 94
2014 94
2015 105
2016 82
2017 77
2018 79
2019 68
2020 91
2021 73
2022 50
2023 48
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

2,418 results

Results by year

Filters applied: . Clear all
Page 1
Pituitary apoplexy.
Wichlińska-Lubińska M, Kozera G. Wichlińska-Lubińska M, et al. Neurol Neurochir Pol. 2019;53(6):413-420. doi: 10.5603/PJNNS.a2019.0054. Epub 2019 Nov 20. Neurol Neurochir Pol. 2019. PMID: 31745969
Pituitary apoplexy (PA) is a clinical syndrome caused by acute haemorrhage and/or infarction of the pituitary gland, generally within a frequently undiagnosed pituitary adenoma. ...This disease is rare but potentially life-threatening without rapid treatment. Because there …
Pituitary apoplexy (PA) is a clinical syndrome caused by acute haemorrhage and/or infarction of the pituitary gland, generally within …
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Ribas A, Puzanov I, Dummer R, Schadendorf D, Hamid O, Robert C, Hodi FS, Schachter J, Pavlick AC, Lewis KD, Cranmer LD, Blank CU, O'Day SJ, Ascierto PA, Salama AK, Margolin KA, Loquai C, Eigentler TK, Gangadhar TC, Carlino MS, Agarwala SS, Moschos SJ, Sosman JA, Goldinger SM, Shapira-Frommer R, Gonzalez R, Kirkwood JM, Wolchok JD, Eggermont A, Li XN, Zhou W, Zernhelt AM, Lis J, Ebbinghaus S, Kang SP, Daud A. Ribas A, et al. Lancet Oncol. 2015 Aug;16(8):908-18. doi: 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115796 Free PMC article. Clinical Trial.
We assessed the efficacy and safety of two pembrolizumab doses versus investigator-choice chemotherapy in patients with ipilimumab-refractory melanoma. METHODS: We carried out a randomised phase 2 trial of patients aged 18 years or older from 73 hospitals, clinics, …
We assessed the efficacy and safety of two pembrolizumab doses versus investigator-choice chemotherapy in patients with ipilimumab-refractor …
Oxytocin therapy in hypopituitarism: Challenges and opportunities.
Bhargava R, Daughters KL, Rees A. Bhargava R, et al. Clin Endocrinol (Oxf). 2019 Feb;90(2):257-264. doi: 10.1111/cen.13909. Epub 2018 Dec 17. Clin Endocrinol (Oxf). 2019. PMID: 30506703 Review.
Patients with hypopituitarism display impaired quality of life and excess morbidity and mortality, despite apparently optimal pituitary hormone replacement. ...This review considers the data linking oxytocin to the neuropsychological and metabolic disturbances evident in p …
Patients with hypopituitarism display impaired quality of life and excess morbidity and mortality, despite apparently optimal pituita …
Hypopituitarism in the elderly.
Antonopoulou M, Sharma R, Farag A, Banerji MA, Karam JG. Antonopoulou M, et al. Maturitas. 2012 Aug;72(4):277-85. doi: 10.1016/j.maturitas.2012.05.002. Epub 2012 Jun 20. Maturitas. 2012. PMID: 22727068 Review.
Pituitary dysfunction in elderly can represent a true diagnostic and therapeutic challenge to clinicians caring for these patients. Symptoms associated with partial or total hypopituitarism, such as fatigue, lower muscle strength and decreased libido, are nonspecific and c …
Pituitary dysfunction in elderly can represent a true diagnostic and therapeutic challenge to clinicians caring for these patients. Symptoms …
Hypopituitarism: growth hormone and corticotropin deficiency.
Capatina C, Wass JA. Capatina C, et al. Endocrinol Metab Clin North Am. 2015 Mar;44(1):127-41. doi: 10.1016/j.ecl.2014.11.002. Epub 2014 Nov 6. Endocrinol Metab Clin North Am. 2015. PMID: 25732649 Review.
Both conditions can result from various ailments affecting the hypothalamus or pituitary gland (most frequently a tumor in the area or its treatment). Clinical manifestations are subtle in AGHD but potentially life-threatening in CAI. ...
Both conditions can result from various ailments affecting the hypothalamus or pituitary gland (most frequently a tumor in the area or its t …
Management of Neonatal Isolated and Combined Growth Hormone Deficiency: Current Status.
Stagi S, Tufano M, Chiti N, Cerutti M, Li Pomi A, Aversa T, Wasniewska M. Stagi S, et al. Int J Mol Sci. 2023 Jun 14;24(12):10114. doi: 10.3390/ijms241210114. Int J Mol Sci. 2023. PMID: 37373261 Free PMC article. Review.
It is sometimes found in isolation but is more frequently associated with multiple pituitary hormone deficiency. In some cases, GHD may have a genetic basis. The many clinical signs and symptoms include hypoglycaemia, neonatal cholestasis and micropenis. ...
It is sometimes found in isolation but is more frequently associated with multiple pituitary hormone deficiency. In some cases, GHD may have …
Lipid profile and response to statin therapy in patients with hypopituitarism.
Rissetti G, Zeni D, Ongaratti BR, Pereira-Lima JFS, Rech CGSL, da Costa Oliveira M. Rissetti G, et al. Arch Endocrinol Metab. 2021 Nov 1;64(6):673-678. doi: 10.20945/2359-3997000000292. Epub 2020 Oct 9. Arch Endocrinol Metab. 2021. PMID: 33049128 Free PMC article.
OBJECTIVE: Dyslipidemia is prevalent among patients with hypopituitarism, especially in those with growth hormone (GH) deficiency. This study aimed to evaluate the response to statin therapy among adult patients with dyslipidemia and hypopituitarism. METHODS: A tota …
OBJECTIVE: Dyslipidemia is prevalent among patients with hypopituitarism, especially in those with growth hormone (GH) deficiency. Th …
Radiotherapy-induced hypopituitarism: a review.
Sathyapalan T, Dixit S. Sathyapalan T, et al. Expert Rev Anticancer Ther. 2012 May;12(5):669-83. doi: 10.1586/era.12.27. Expert Rev Anticancer Ther. 2012. PMID: 22594901 Review.
Mostly, RIH involves one hypothalamic-pituitary axis; however, multiple hormonal axes deficiency starts developing at higher doses. Although the clinical effects of the hypopituitarism are more profound in children and young adults, its implications in older adults …
Mostly, RIH involves one hypothalamic-pituitary axis; however, multiple hormonal axes deficiency starts developing at higher doses. Although …
Treating Hypopituitarism in the Over 65s: Review of Clinical Studies.
Paragliola RM, Locantore P, Corsello SM, Salvatori R. Paragliola RM, et al. Clin Interv Aging. 2023 Mar 21;18:423-439. doi: 10.2147/CIA.S370782. eCollection 2023. Clin Interv Aging. 2023. PMID: 36974195 Free PMC article. Review.
The current increase of life expectancy is associated with the presence of endocrine diseases in the elderly. The management of hypopituitarism in this group of patients is a challenging task. A correct diagnosis, which represents an essential requisite for an appropriate …
The current increase of life expectancy is associated with the presence of endocrine diseases in the elderly. The management of hypopitui …
2,418 results